NCT05767827

Effect of Dexmedetomidine As Adjuvant to Ropivacaine for Brachial Plexus Block

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Nepal Medical College and Teaching Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

Brachial plexus block is used for upper limb surgery. Local anesthesia alone for brachial plexus block provides good operative conditions, but have short duration of postoperative analgesia. Hence, various adjuvants to local anaesthetic agents to prolong the duration of peripheral nerve, analgesia. However, results are either inconclusive or associated with side effects. The purpose of this study is to determine whether dexmedetomidine as an adjuvant to ropivacaine in brachial plexus block improve quality of block in terms of duration of post operative analgesia.

Conditions

• Local Anesthesia Adjuvants
• Upper Extremity Fracture
• Brachial Plexus Block

Interventions

Type	Name	Description
DRUG	ropivacaine, lidocaine with adrenaline	Group R includes 0.35% ropivacaine 20ml, 1.5 % lidocaine with adrenaline 10ml
DRUG	Dexmedetomidine, ropivacaine, lidocaine with adrenaline	Dexmedetomidine 1mcg/kg and 0.35% ropivacaine with normal saline (20ml), 1.5% lidocaine with adrenaline (10ml) in group RD

Timeline

• Start date: 2023-02-01
• Primary completion: 2023-07-30
• Completion: 2024-08-30
• First posted: 2023-03-14
• Last updated: 2024-09-04

Locations

1 site across 1 country: Nepal